News

3 Reasons BIIB is Risky and 1 Stock to Buy Instead

Shareholders of Biogen would probably like to forget the past six months even happened. The stock dropped 31.4% and now trades at $140.49. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

US tariffs will likely dent growth prospects in Central Europe, S&P Global says

U.S. President Donald Trump's proposal to impose 25% tariffs on imports from the European Union is likely to dent growth prospects in Central Europe, compounding existing fiscal challenges, S&P Global Ratings told Reuters. Trump said last week his administration would soon announce the tariffs on goods from the EU, which the Republican leader said had been created to "screw" the United States.